Compassionate Drug Availability Act of 1981

Summary

Compassionate Drug Availability Act of 1981 - Amends the Federal Food, Drug, and Cosmetic Act to define: (1) "orphan drug" as a drug which is or may be unique or provide an advance in the diagnosis, prevention, or treatment of a human disease or condition of low incidence and has little or no projected commercial value; and (2) "individual compassionate drug treatment" as those treatments primarily intended to provide diagnosis, treatment, or prevention for users rather than to assess the risks and effectiveness of the drug product. Exempts orphan drugs and compassionate drug treatments from application and certification requirements under such Act, except that practitioners administering such care shall maintain case records of medical treatment and conform to applicable rules and regulations pertaining to investigational use. Allows orphan drugs to be exported if the Secretary of Health and Human Services determines that such drugs are not contrary to public health and safety and are approved by the countries intended for export.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 27 April 1981

   Introduced

   Referred to House Committee on Energy and Commerce.

   Source: IntroReferral

2. 27 April 1981

   Introduced

   Introduced in House

   Source: IntroReferral

3. 27 April 1981

   Introduced

   Introduced in House

   Source: IntroReferral

4. 30 April 1981

   Referred

   Referred to Subcommittee on Health and the Environment.

   Source: Committee

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Introduced in House

  summary · EN · 27 April 1981

  Open at official source

Sponsors

• Rep. Scheuer, James H. [D-NY-8] · D · Sponsor
• Rep. Carney, William [R-NY-1] · R · Sponsor
• · hsif00 · Standing

Related records

No cross-record relationships stored yet.